Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

NCT03471117 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Diseases

Interventions

DRUG: Pioglitazone
OTHER: Placebo

Sponsor

The University of Texas at Arlington

Collaborators

[object Object]